These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19250756)

  • 1. Why do Alzheimer's disease and Parkinson's disease target the same neurons?
    Eggers AE
    Med Hypotheses; 2009 Jun; 72(6):698-700. PubMed ID: 19250756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview.
    Mariani E; Polidori MC; Cherubini A; Mecocci P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 827(1):65-75. PubMed ID: 16183338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease.
    Aliev G; Palacios HH; Walrafen B; Lipsitt AE; Obrenovich ME; Morales L
    Int J Biochem Cell Biol; 2009 Oct; 41(10):1989-2004. PubMed ID: 19703659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of neuronal energy crisis in Alzheimer's disease.
    de la Torre JC
    Neurodegener Dis; 2008; 5(3-4):126-32. PubMed ID: 18322369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can we prevent Parkinson's and Alzheimer's disease?
    Kedar NP
    J Postgrad Med; 2003; 49(3):236-45. PubMed ID: 14597787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?
    Rogers J; Mastroeni D; Leonard B; Joyce J; Grover A
    Int Rev Neurobiol; 2007; 82():235-46. PubMed ID: 17678964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the unfolded protein response is an early event in Alzheimer's and Parkinson's disease.
    Hoozemans JJ; van Haastert ES; Nijholt DA; Rozemuller AJ; Scheper W
    Neurodegener Dis; 2012; 10(1-4):212-5. PubMed ID: 22302012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease, motoneuron disease and Alzheimer's disease: origins and interrelationship.
    Calne DB; Eisen A
    Adv Neurol; 1990; 53():355-60. PubMed ID: 2239477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress signalling in Alzheimer's disease.
    Zhu X; Raina AK; Lee HG; Casadesus G; Smith MA; Perry G
    Brain Res; 2004 Mar; 1000(1-2):32-9. PubMed ID: 15053949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A modern hypothesis: The distinct pathologies of dementia associated with Parkinson's disease versus Alzheimer's disease.
    Farlow MR; Cummings J
    Dement Geriatr Cogn Disord; 2008; 25(4):301-8. PubMed ID: 18311077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease.
    Aliev G; Smith MA; de la Torre JC; Perry G
    Mitochondrion; 2004 Sep; 4(5-6):649-63. PubMed ID: 16120422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes.
    Moreira PI; Santos MS; Seiça R; Oliveira CR
    J Neurol Sci; 2007 Jun; 257(1-2):206-14. PubMed ID: 17316694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis.
    Altamura S; Muckenthaler MU
    J Alzheimers Dis; 2009; 16(4):879-95. PubMed ID: 19387120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial aging and dysfunction in Alzheimer's disease.
    Sullivan PG; Brown MR
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Mar; 29(3):407-10. PubMed ID: 15795049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear microscope analysis in Alzheimer's and Parkinson's disease: A review.
    Watt F
    Cell Mol Biol (Noisy-le-grand); 1996 Feb; 42(1):17-26. PubMed ID: 8833663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress and neurotoxicity.
    Sayre LM; Perry G; Smith MA
    Chem Res Toxicol; 2008 Jan; 21(1):172-88. PubMed ID: 18052107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maillard reaction versus other nonenzymatic modifications in neurodegenerative processes.
    Pamplona R; Ilieva E; Ayala V; Bellmunt MJ; Cacabelos D; Dalfo E; Ferrer I; Portero-Otin M
    Ann N Y Acad Sci; 2008 Apr; 1126():315-9. PubMed ID: 18079479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commonalities in the genetics of Alzheimer's disease and Parkinson's disease.
    Grünblatt E
    Expert Rev Neurother; 2008 Dec; 8(12):1865-77. PubMed ID: 19086884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurochemical abnormalities in Alzheimer's disease and Parkinson's disease--a comparative review.
    Gsell W; Strein I; Krause U; Riederer P
    J Neural Transm Suppl; 1997; 51():145-59. PubMed ID: 9470135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research in motion: the enigma of Parkinson's disease pathology spread.
    Brundin P; Li JY; Holton JL; Lindvall O; Revesz T
    Nat Rev Neurosci; 2008 Oct; 9(10):741-5. PubMed ID: 18769444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.